Dr. Reddy's Laboratories Limited

NSE: DRREDDY BSE: DRREDDY

NSE
1,270.80 -6.00 (-0.47%)

Prev Close

1276.8

Open Price

1276

Volume

2,026,896

Today Low / High

1263.7 / 1280.9

52 WK Low / High

1020 / 1421.49

Range

1,207 - 1,334

Upper Circuit (5%)

1,334.34

Lower Circuit (5%)

1,207.26

BSE
1,271.75 -5.20 (-0.41%)

Prev Close

1276.95

Open Price

1274.15

Volume

33,929

Today Low / High

1263.85 / 1280.05

52 WK Low / High

1025.9 / 1420.2

Range

1,208 - 1,335

Upper Circuit (5%)

1,335.34

Lower Circuit (5%)

1,208.16

The stock performance of Dr. Reddy's Laboratories Limited on both the NSE and BSE. On the NSE, the stock is priced at ₹1270.8 (target range: ₹1,207 - ₹1,334), reflecting a slight increase of -0.47%, with a trading volume of 2,026,896 shares. On the BSE, the stock is trading at ₹1271.75 (target range: ₹1,208 - ₹1,335), up by -0.41% with a volume of 33,929 shares. Both exchanges show similar low and high prices, with NSE at ₹1263.7 - ₹1280.9 and BSE at ₹1263.85 - ₹1280.05 The 52-week range stands at ₹1421.49 - ₹1020 on both exchanges. The stock is declining on both exchanges, indicating a downtrend. Monitor closely before making investment decisions.

Dr. Reddy's Laboratories Limited Chart

Comprehensive Overview of Dr. Reddy's Laboratories Limited

ISIN

INE089A01023

Industry

Drug Manufacturers - Specialty & Generic

Vol.Avg

2,095,708

Market Cap

1,057,406,933,592

Last Dividend

8

Range

1020-1421.49

Official Website

Visit Website

IPO Date

1996-01-01

DCF Diff

-1,057.18

DCF

2,323

In-Depth Stock Rating of Dr. Reddy's Laboratories Limited

MetricValueRecommendation
Overall Rating A Buy
DCF Score5Strong Buy
ROE Score4Buy
ROA Score5Strong Buy
Debt-to-Equity (DE) Score3Neutral
Price-to-Earnings (PE) Score2Sell
Price-to-Book (PB) Score3Neutral

Latest Dividend Details of Dr. Reddy's Laboratories Limited

DateLabelAdj DividendDividendRecord DatePayment DateDeclaration Date
2025-07-10July 10, 25882025-07-102025-08-23
2024-07-16July 16, 248402024-07-162024-08-28
2023-07-11July 11, 23402002023-07-112023-08-26
2022-07-11July 11, 22301502022-07-122022-08-28
2021-07-09July 09, 215252021-07-122021-08-27

Comprehensive Annual Financial Performance Report of Dr. Reddy's Laboratories Limited

DateRevenueCo.RevGPGPRR&D ExpensesG&A ExpensesOperating IncomeNet IncomeEPSEBITDANIR
2025-03-3132,553.50 Cr13,510.70 Cr19,042.80 Cr0.58502,738.00 Cr0.00 Cr7,184.30 Cr5,654.40 Cr67.889,161.10 Cr0.1737
2024-03-3127,916.40 Cr11,555.70 Cr16,360.70 Cr0.58612,287.30 Cr0.00 Cr6,772.90 Cr5,568.40 Cr334.418,827.50 Cr0.1995
2023-03-3124,587.90 Cr7,657.70 Cr16,930.20 Cr0.68861,938.10 Cr4,646.60 Cr5,714.40 Cr4,506.70 Cr271.437,406.10 Cr0.1833
2022-03-3121,439.10 Cr10,055.10 Cr11,384.00 Cr0.53101,748.20 Cr0.00 Cr2,947.60 Cr2,356.80 Cr142.084,774.30 Cr0.1099
2021-03-3118,972.20 Cr8,664.50 Cr10,307.70 Cr0.54331,654.10 Cr0.00 Cr2,619.10 Cr1,723.80 Cr103.944,570.60 Cr0.0909

Essential Financial Ratios Every Investor Must Know of Dr. Reddy's Laboratories Limited

Comprehensive Annual Balance Sheet Overview of Dr. Reddy's Laboratories Limited

DateC&C Equ.Tot. AssetsTot. Liab.Stock. EquityTot. DebtNet DebtInv.PP&E (Net)Curr. Def. Rev.Non-Curr. Def. Rev.LT Invest.Curr. Liab.
2025-03-311,465.40 Cr49,298.90 Cr15,582.30 Cr33,338.8000 Cr4,676.60 Cr3,211.20 Cr7,108.50 Cr9,776.10 Cr0.00 Cr0.00 Cr1,520.20 Cr13,039.2000 Cr
2024-03-31710.70 Cr38,751.80 Cr10,696.80 Cr28,055.0000 Cr2,002.00 Cr1,291.30 Cr6,355.20 Cr7,688.60 Cr143.50 Cr119.30 Cr525.50 Cr9,603.9000 Cr
2023-03-31577.90 Cr32,285.10 Cr8,999.00 Cr23,286.1000 Cr1,347.20 Cr769.30 Cr4,867.00 Cr5,654.20 Cr198.10 Cr155.50 Cr608.90 Cr8,572.1000 Cr
2022-03-311,485.20 Cr29,665.40 Cr10,612.70 Cr19,052.7000 Cr3,384.50 Cr1,899.30 Cr5,088.40 Cr6,216.90 Cr257.60 Cr159.70 Cr798.60 Cr9,784.2000 Cr
2021-03-311,482.90 Cr26,549.10 Cr9,051.00 Cr17,498.1000 Cr3,030.80 Cr1,547.90 Cr4,541.20 Cr5,711.10 Cr203.30 Cr153.10 Cr833.30 Cr8,147.2000 Cr

Annual Financial Cash Flow Statement Overview of Dr. Reddy's Laboratories Limited

DateOperating CashInvesting CashFinancing CashFree CashCash ChangeCash at EndCapExIncomeDebt RepayDividendsInventory
2025-03-314,642.8000 Cr-5,102.1000 Cr1,185.5000 Cr1,892.4000 Cr748.6000 Cr1,459.3000 Cr-2,750.4000 Cr5,654.4000 Cr-129.4000 Cr-666.2000 Cr-1,275.3000 Cr
2024-03-314,543.3000 Cr-4,028.3000 Cr-376.3000 Cr1,799.8000 Cr132.8000 Cr710.7000 Cr-2,743.5000 Cr5,568.4000 Cr434.6000 Cr-664.8000 Cr-1,844.5000 Cr
2023-03-315,887.3000 Cr-4,137.1000 Cr-2,686.1000 Cr4,000.9000 Cr-907.3000 Cr577.9000 Cr-1,886.4000 Cr6,048.5000 Cr-1,938.2000 Cr-497.9000 Cr-265.4000 Cr
2022-03-312,810.8000 Cr-2,638.7000 Cr-242.2000 Cr905.9000 Cr3.2000 Cr1,485.2000 Cr-1,904.9000 Cr2,356.8000 Cr273.5000 Cr-414.6000 Cr-532.8000 Cr
2021-03-313,570.3000 Cr-2,266.0000 Cr-29.8000 Cr2,314.2000 Cr1,285.8000 Cr1,482.0000 Cr-1,256.1000 Cr1,914.9000 Cr-69.7000 Cr-414.7000 Cr-988.1000 Cr

Quarterly Financial Performance Highlights of Dr. Reddy's Laboratories Limited

DateRevenueCo.RevGPGPROperating IncomeNet IncomeEPSEBITDANIR
2025-03-318,506.00 Cr3,779.70 Cr4,726.30 Cr0.55561,764.70 Cr1,593.90 Cr19.132,141.80 Cr0.1874
2024-12-318,358.60 Cr3,453.40 Cr4,905.20 Cr0.58681,872.00 Cr1,413.30 Cr16.962,423.70 Cr0.1691
2024-09-308,016.20 Cr3,458.10 Cr4,558.10 Cr0.56861,755.10 Cr1,255.30 Cr15.042,383.80 Cr0.1566
2024-06-307,672.70 Cr3,250.10 Cr4,422.60 Cr0.57641,754.20 Cr1,392.00 Cr83.582,175.70 Cr0.1814
2024-03-317,083.00 Cr2,934.70 Cr4,148.30 Cr0.58571,413.00 Cr1,307.00 Cr78.492,028.60 Cr0.1845

Comprehensive Quarterly Financial Balance Sheet of Dr. Reddy's Laboratories Limited

DateCash & Equiv.Short-Term Inv.Cash & Short-TermNet ReceivablesInventoryTotal Curr. AssetsPP&E (Net)Total AssetsTotal Liabilities
2025-03-311,465.40 Cr4,325.40 Cr5,790.80 Cr9,042.00 Cr7,108.50 Cr25,011.20 Cr9,776.10 Cr49,298.90 Cr15,582.30 Cr
2024-12-311,228.90 Cr4,689.00 Cr5,917.90 Cr11,149.40 Cr7,163.00 Cr25,301.60 Cr9,305.30 Cr48,105.90 Cr15,949.40 Cr
2024-09-301,133.00 Cr5,174.40 Cr6,307.40 Cr9,190.30 Cr7,203.90 Cr24,812.80 Cr8,669.30 Cr46,595.50 Cr15,667.20 Cr
2024-06-30491.30 Cr8,971.30 Cr9,462.60 Cr8,108.80 Cr6,856.80 Cr26,918.80 Cr8,034.30 Cr41,529.70 Cr12,067.00 Cr
2024-03-31710.70 Cr7,436.30 Cr8,147.00 Cr8,029.80 Cr6,355.20 Cr24,804.90 Cr7,688.60 Cr38,751.80 Cr10,696.80 Cr

Quarterly Cash Flow Statement: A Detailed Financial Overview of Dr. Reddy's Laboratories Limited

DateNet IncomeOperating Cash FlowInvesting Cash FlowFinancing Cash FlowNet Cash ChangeCash at EndCash at BeginningCapExFree Cash Flow
2025-03-311,593.90 Cr2,199.60 Cr-624.40 Cr-1,442.60 Cr156.10 Cr1,459.30 Cr1,303.20 Cr-766.20 Cr1,433.40 Cr
2024-12-311,403.80 Cr662.00 Cr-545.80 Cr59.00 Cr174.70 Cr1,303.20 Cr1,128.50 Cr-881.90 Cr-219.90 Cr
2024-09-301,255.30 Cr931.60 Cr-1,284.90 Cr1,003.10 Cr637.20 Cr1,128.50 Cr491.30 Cr-790.90 Cr140.70 Cr
2024-06-301,392.00 Cr819.80 Cr-2,069.40 Cr1,028.50 Cr-219.40 Cr491.30 Cr710.70 Cr-642.40 Cr177.40 Cr
2024-03-311,307.00 Cr1,129.00 Cr-1,177.80 Cr14.00 Cr-42.80 Cr710.70 Cr753.50 Cr-628.30 Cr500.70 Cr

Historical Stock Splits Overview of Dr. Reddy's Laboratories Limited

DateLabelSplit Ratio
2024-10-28October 28, 245:1
2006-08-28August 28, 062:1
2001-10-10October 10, 012:1

Executive Profiles of Dr. Reddy's Laboratories Limited

Executive Vice President, Global Head of Global Manufacturing & Member of Management Council
Mr. Sanjay Sharma B.Tech.

Gender: male

Year Born: 1968

Chief Executive Officer of API & Services & Member of Management Council
Mr. Deepak Sapra M.B.A.

Gender: male

Year Born: 1975

EVice President, Head of Corporate Communications, Chief Human Resources Officer & Member of Management Council
Ms. Archana Bhaskar B.Sc., M.B.A.

Gender: female

Year Born: 1967

Co-Chairman, MD & Member of Management Council
Mr. Gunupati Venkateswara Prasad B.E.

Gender: male

Year Born: 1960

Chief Executive Officer of European Generics & Member of Management Council
Mr. Patrick Aghanian B.A., M.B.A.

Gender: male

Year Born: 1965

Global Head of Quality and Pharmacovigilance & Member of the Management Council
Mr. Krishna K. Venkatesh B.Pharma M.S.

Gender: male

Year Born: 1973

Chief Executive Officer of Branded Markets - India & Emerging Countries and Member of Management Council
Mr. Venkata Ramana Motupalli M.B.A.

Gender: male

Year Born: 1969

Chief Financial Officer & Member of the Management Council
Mr. Mannam Venkatanarasimham

Gender: male

Year Born:

Chairman of the Board & Member of the Management Council
Mr. Kallam Satish Reddy B.Tech., M.S.

Gender: male

Year Born: 1967

Chief Executive Officer & Member of the Management Council
Mr. Erez Israeli M.B.A.

Gender: male

Year Born: 1968

Frequently Asked Questions about Dr. Reddy's Laboratories Limited

The CEO of the company is Erez Israeli.

The current trading price of the stock is ₹1,270.80.

The 52-week price range of this stock is ₹1020-1421.49.

The market capitalization of the company is ₹105,740.69 crores.

The dividend yield represents the percentage of a company stock price paid out as dividends annually. For example, if the dividend yield is 0.63%, it means the company pays this percentage of its stock price as a dividend each year.

The P/E ratio is a measure of a company stock price relative to its earnings per share (EPS). For this stock, the current P/E ratio is 18.71.

The company operates in the Healthcare sector.

The current price of Dr. Reddy's Laboratories Limited is ₹1,270.80. If the stock takes a bullish turn, you can expect the target price to be around ₹1,334.34. On the other hand, if the market turns bearish, the target price could drop to approximately ₹1,207.26.

The company, Dr. Reddy's Laboratories Limited (ISIN: INE089A01023), is a leading player in the Drug Manufacturers - Specialty & Generic sector in India. With a market capitalization of ₹105,740.69 crores and an average daily trading volume of 2,095,708 shares, it is actively engaged in the Drug Manufacturers - Specialty & Generic industry. The company recently declared a dividend of 8."

Scroll to Top
Save your Brokerage Now! Open Free Demat Account